Results 201 to 210 of about 251,408 (329)
Granulomatous Panniculitis in a Patient Treated With Cemiplimab: Case Report and Literature Review
ABSTRACT Immune checkpoint inhibitors (ICIs) have become a cornerstone in the treatment of advanced malignancies by enhancing antitumor immunity, but they may also trigger a broad spectrum of immune‐related adverse events (irAEs) involving multiple organs.
B. Lada‐Colunga +6 more
wiley +1 more source
Management of Clinical Cardiac Sarcoidosis Isolated to the Heart With Tumor Necrosis Factor-Alpha Inhibitors. [PDF]
Malhi JK +6 more
europepmc +1 more source
ABSTRACT Diffuse large B‐cell lymphoma (DLBCL) is the most common non‐Hodgkin lymphoma and is an aggressive and highly heterogeneous tumor. Kaempferitrin (KPF) is a natural flavonoid glycoside that exerts a protective role in multiple human tumors. However, the impact of KPF on DLBCL remains unclear.
Han‐Shuo Zhang +3 more
wiley +1 more source
Atypical presentation of DRESS/DiHS mimicking an acquired ichthyosis: A case report of bortezomib-induced severe erythroderma in multiple myeloma. [PDF]
Lu C +5 more
europepmc +1 more source
A Case of Palmoplantar Vesiculobullous Lesions
JEADV Clinical Practice, EarlyView.
Ali Abid +3 more
wiley +1 more source
ABSTRACT This study evaluated the prognostic value of the C‐PLAN index in advanced esophageal squamous cell carcinoma (ESCC) patients receiving immune checkpoint inhibitor (ICI) therapy. A retrospective analysis of 241 eligible patients treated during February 2020 to January 2023 was conducted.
Yi Zhou +5 more
wiley +1 more source
Lupus miliaris disseminatus faciei with madarosis: A novel presentation. [PDF]
Su Y, Cui W.
europepmc +1 more source

